Abstract: The invention discloses a method of preparing monodisperse microtablets of calcium carbonate in aqueous solutions containing calcium, gelatin and urea. Calcium carbonate powders of a unique tablet-like morphology were produced by simply ageing the prerefrigerated (at 4° C. for at least 24 hours) CaCI2-gelatin-urea solutions at 70° C. for 24 h in ordinary glass media bottles. Thermal decomposition of dissolved urea was used to supply aqueous carbonate (CO32?) ions to the calcium (Ca2+) ion and gelatin-containing solutions. Monodisperse CaCO3 microtablets have the particle sizes from 1 to 8 microns. CaCO3 microtablets were biphasic in nature and consist of 93 to 98% vaterite and 2 to 7% calcite. Identical solutions used without prerefrigeration yielded only trigonal prismatic calcite crystals upon ageing at 70° C. for 24 h.

Abstract: The invention discloses a method of preparing monodisperse microtablets of calcium carbonate in aqueous solutions containing calcium, gelatin and urea. Calcium carbonate powders of a unique tablet-like morphology were produced by simply ageing the prerefrigerated (at 4° C. for at least 24 hours) CaCI2-gelatin-urea solutions at 70° C. for 24 h in ordinary glass media bottles. Thermal decomposition of dissolved urea was used to supply aqueous carbonate (CO32?) ions to the calcium (Ca2+) ion and gelatin-containing solutions. Monodisperse CaCO3 microtablets have the particle sizes from 1 to 8 microns. CaCO3 microtablets were biphasic in nature and consist of 93 to 98% vaterite and 2 to 7% calcite. Identical solutions used without prerefrigeration yielded only trigonal prismatic calcite crystals upon ageing at 70° C. for 24 h.

Abstract: The invention describes a method of preparing macroporous calcium phosphate granules with NaCl porogen technique, wherein a calcium phosphate self-setting cement powder is mixed with 30 to 80 wt % NaCl. The calcium phosphate granules comprise macro- and micropores communicating with one another substantially throughout the body with a porosity of 40% or more and having the same mineral as those of human bones. Said granules are used as a substitute or repairing material for bone, carrier material for drug delivery and gradual release system.

Abstract: The invention describes a new calcium phosphate cement powder, whose composition can best be described over the Ca/P molar ratio range of 1.35 to 1.40, most preferably 1.39, and whose two components were prepared by wet chemical synthesis procedures. One component is chemically-synthesized, bi-phasic alpha-TCP (Ca3(PO4)2, 95 wt %)+HA (Ca10(PO4)6(OH)2, 5 wt %) powder, while the second component is again a chemically-synthesized, single-phase DCPD (CaHPO4·2H2O) powder. A setting solution (Na2HPO4·2H2O) is used to form a self-setting calcium phosphate cement from the powder mixture. This cement can be used as bone filler or bone substitute in applications, which require higher rates of resorption.